Use access key #2 to skip to page content.
$11.44 -0.24 (-2.05%)
8/21/2008 4:00 PM

BioMimetic Therapeutics, Inc. (BMTI)

CAPS Rating:
**

The Company develops and commercializes bio-active drug-device combination products for the healing of musculoskeletal injuries and diseases, including periodontal, orthopedic, spine and sports injury applications.

View All Commentary (BMTI)

Recs

0

Avatar TheTazzBot (< 20) Submitted: 4/03/08 8:03 PM : Outperform Start Price: $9.51 BMTI Score: 27.54

Expect this stock to climb back to its peak, or 80% of its peak in a few weeks

Report this Post Replies: 0 | Reply

Featured Broker Partners